Tenon Medical, Inc. (TNON)
NASDAQ: TNON · Real-Time Price · USD
0.7256
+0.0496 (7.34%)
At close: Mar 31, 2026, 4:00 PM EDT
0.7409
+0.0153 (2.11%)
After-hours: Mar 31, 2026, 7:48 PM EDT
Tenon Medical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Tenon Medical stock has a target of 3.00, which predicts a 313.45% increase from the current stock price of 0.73.
Price Target: $3.00 (+313.45%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 9, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Tenon Medical is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +313.45% | Apr 9, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $22 → $8 | Strong Buy | Maintains | $22 → $8 | +1,002.54% | Nov 15, 2024 |
| Benchmark | Benchmark | Buy Reiterates $24 | Buy | Reiterates | $24 | +3,207.61% | Aug 14, 2024 |
| Benchmark | Benchmark | Buy Maintains $40 → $24 | Buy | Maintains | $40 → $24 | +3,207.61% | Apr 15, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $480 | Strong Buy | Reiterates | $480 | +66,052.15% | Mar 10, 2023 |
Financial Forecast
Revenue This Year
6.70M
from 3.94M
Increased by 69.93%
Revenue Next Year
9.94M
from 6.70M
Increased by 48.34%
EPS This Year
-0.99
from -1.70
EPS Next Year
-0.75
from -0.99
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 8.0M | 13.0M | |||
| Avg | 6.7M | 9.9M | |||
| Low | 5.4M | 7.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 103.2% | 93.3% | |||
| Avg | 69.9% | 48.3% | |||
| Low | 36.9% | 4.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.89 | -0.63 | |||
| Avg | -0.99 | -0.75 | |||
| Low | -1.08 | -0.85 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.